Enhancement of Impaired Olfactory Neural Activation and Cognitive Capacity by Liraglutide, but Not Dapagliflozin or Acarbose, in Patients With Type 2 Diabetes: A 16-Week Randomized Parallel Comparative Study-MedSci.cn

Enhancement of Impaired Olfactory Neural Activation and Cognitive Capacity by Liraglutide, but Not Dapagliflozin or Acarbose, in Patients With Type 2 Diabetes: A 16-Week Randomized Parallel Comparative Study

Cheng, HY; Zhang, Z; Zhang, B; Zhang, W; Wang, J; Ni, WY; Miao, YW; Liu, JN; Bi, Y

Bi, Y (通讯作者)，Nanjing Med Univ, Dept Endocrinol, Nanjing Drum Tower Hosp, Clin Coll,Branch Natl Clin Res Ctr Metab Dis, Nanjing, Peoples R China.;Bi, Y (通讯作者)，Nanjing Univ, Sch Med, Dept Endocrinol, Nanjing Drum Tower Hosp,Affiliated Hosp, Nanjing, Peoples R China.

DIABETES CARE, 2022; 45 (5): 1201

Abstract

OBJECTIVE The comparative neuroprotective effects of different antidiabetes drugs have not been characterized in randomized controlled trials. Here, w......

Full Text Link

Links

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

Enhancement of Impaired Olfactory Neural Activation and Cognitive Capacity by Liraglutide, but Not Dapagliflozin or Acarbose, in Patients With Type 2 Diabetes: A 16-Week Randomized Parallel Comparative Study

科室

工具

服务